-
EP0784691
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0784691
| EP0784691 - ADENOVIRUS-DERIVED VIRAL VECTORS HAVING TWO THERAPEUTIC GENES: SUICIDE AND IMMUNOPOTENTIATING [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 14.09.2007 Database last updated on 12.06.2024 | Most recent event Tooltip | 14.09.2007 | Withdrawal of application | published on 17.10.2007 [2007/42] | Applicant(s) | For all designated states CENTELION 72-82 rue Léon Geffroy 94400 Vitry Sur Seine / FR | [N/P] |
| Former [2005/09] | For all designated states CENTELION 72-82 rue Leon Geffroy 94400 Vitry Sur Seine / FR | ||
| Former [1997/30] | For all designated states RHONE-POULENC RORER S.A. 20, avenue Raymond Aron 92160 Antony / FR | Inventor(s) | 01 /
DENEFLE, Patrice 45, avenue des Fusillés-de-Chateaubriand F-94100 Saint-Maur / FR | 02 /
PERRICAUDET, Michel 31, rue de Chartres F-28320 Ecrosnes / FR | 03 /
TOCQUE, Bruno 58, boulevard Saint-Denis F-92400 Courbevoie / FR | [1997/30] | Representative(s) | Lecca, Patricia S. CENTELION 72-82, rue Léon Geffroy 94400 Vitry sur Seine / FR | [N/P] |
| Former [2005/09] | Lecca, Patricia S. CENTELION 72-82, rue Léon Geffroy 94400 Vitry sur Seine / FR | ||
| Former [2004/35] | Lecca, Patricia Gencell SAS 72-82, rue Léon Geffroy 94400 Vitry-sur-Seine / FR | ||
| Former [1997/30] | Becker, Philippe Rhône-Poulenc Rorer S.A., Direction Brevets, 20 avenue Raymond Aron 92165 Antony Cédex / FR | Application number, filing date | 95933464.0 | 02.10.1995 | [1997/30] | WO1995FR01274 | Priority number, date | FR19940011846 | 04.10.1994 Original published format: FR 9411846 | [1997/30] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | WO9610642 | Date: | 11.04.1996 | Language: | FR | [1996/16] | Type: | A1 Application with search report | No.: | EP0784691 | Date: | 23.07.1997 | Language: | FR | The application published by WIPO in one of the EPO official languages on 11.04.1996 takes the place of the publication of the European patent application. | [1997/30] | Search report(s) | International search report - published on: | EP | 11.04.1996 | Classification | IPC: | C12N15/86, A61K48/00, C07K14/55, C07K14/535, C07K14/035, C07K14/82 | [1997/30] | CPC: |
C07K14/005 (EP);
A61P35/00 (EP);
A61P37/04 (EP);
C07K14/535 (EP);
C07K14/55 (EP);
C07K14/82 (EP);
C12N15/86 (EP);
A61K48/00 (EP);
C12N2710/10343 (EP);
C12N2710/16622 (EP);
C12N2830/00 (EP);
C12N2830/002 (EP);
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1997/30] | Title | German: | VORSCHALTBARE DÄMPFUNGSEINHEIT ZUR DÄMPFUNG VON ROTATIONSSCHWINGUNGEN | [1997/30] | English: | ADENOVIRUS-DERIVED VIRAL VECTORS HAVING TWO THERAPEUTIC GENES: SUICIDE AND IMMUNOPOTENTIATING | [1997/30] | French: | ADENOVIRAUX COMPRENANT DEUX GENES THERAPEUTIQUES: SUICIDE ET IMMUNOSTIMULANT | [1997/30] | Entry into regional phase | 01.04.1997 | National basic fee paid | 01.04.1997 | Designation fee(s) paid | 01.04.1997 | Examination fee paid | Examination procedure | 22.04.1996 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 01.04.1997 | Examination requested [1997/30] | 05.09.2003 | Despatch of a communication from the examining division (Time limit: M06) | 19.04.2004 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 15.06.2004 | Reply to a communication from the examining division | 19.12.2005 | Despatch of a communication from the examining division (Time limit: M01) | 30.01.2006 | Reply to a communication from the examining division | 28.08.2007 | Application withdrawn by applicant [2007/42] | 28.08.2007 | Cancellation of oral proceeding that was planned for 30.10.2007 | 28.08.2007 | Minutes of oral proceedings despatched | 30.10.2007 | Date of oral proceedings (cancelled) | Request for further processing for: | 15.06.2004 | Request for further processing filed | 15.06.2004 | Full payment received (date of receipt of payment) Request granted | 05.07.2004 | Decision despatched | Fees paid | Renewal fee | 24.09.1997 | Renewal fee patent year 03 | 23.09.1998 | Renewal fee patent year 04 | 20.09.1999 | Renewal fee patent year 05 | 22.09.2000 | Renewal fee patent year 06 | 15.10.2001 | Renewal fee patent year 07 | 15.10.2002 | Renewal fee patent year 08 | 14.10.2003 | Renewal fee patent year 09 | 14.10.2004 | Renewal fee patent year 10 | 12.10.2005 | Renewal fee patent year 11 | 12.10.2006 | Renewal fee patent year 12 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO9321959 (US HEALTH [US]) [Y] 1-27 * claims 1,4-15,18-24,26 *; | [Y]WO9310218 (US HEALTH [US], et al) [Y] 1-27 * claims 1,2,4-11 *; | [Y]FR2688514 (CENTRE NAT RECH SCIENT [FR]) [Y] 1-16,18,20-27 * page 1, line 20 - page 3, line 27; figure 1; claim 6 *; | [PY]FR2707664 (CENTRE NAT RECH SCIENT [FR], et al) [PY] 1-27 * page 2, line 30 - line 34 * * page 5, line 31 - page 6, line 24; claims 9,10 *; | [PX]WO9424297 (RHONE POULENC RORER SA [FR], et al) [PX] 1-17,19,22-27 * claims 1-5,9-16 *; | [PY]WO9426914 (RHONE POULENC RORER SA [FR], et al) [PY] 1-27 * page 3, line 27 - page 5, line 12; claims 10-18 *; | [PX]WO9500655 (UNIV MCMASTER [CA]) [PX] 1-27 * page 4, line 11 - page 6, line 14 * * page 23, line 14 - page 27, line 16; figures 7,8; claim 14 *; | [PY]WO9514102 (RHONE POULENC RORER SA [FR], et al) [PY] 1 * the whole document *; | [A]WO9412649 (GENZYME CORP [US]) [A] 1 * figure 32 *; | [PY]WO9428152 (TRANSGENE SA [FR], et al) [PY] 1 * page 30, line 1 - line 25 * * page 18, line 26 - page 19, line 5 * * page 11, line 4 - page 12, line 17; claim - *; | [Y]WO8800971 (COMMW SCIENT IND RES ORG [AU], et al) [Y] 1 * page 8, line 20 - page 9, line 3; figures 1-4; example 1; claim - * | [Y] - SHEWACH, D. S. ET AL., "Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in glioma cells", CANCER GENE THERAPY, vol. 1, no. 2, pages 107 - 112 [Y] 1-27 * the whole document * | [Y] - WILLS, K.N. ET AL., "Tumor suppressor gene therapy of cancer. Adenoviral mediated gene transfer of p53 and retinoblastoma cDNA into human tumor cell lines", JOURNAL OF CELLULAR BIOCHEMISTRY, (19940213), vol. SUPPL, no. 18C, page 204 [Y] 1-17,19,22-27 * Résumé N 524 * | [Y] - CHEN, S.H. ET AL., "Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., WASHINGTON US, vol. 91, no. 8, pages 3054 - 3057 [Y] 1-27 * the whole document * | [X] - ZHANG, W.W. ET AL., "High-efficiency gene transfer and high level expression of wild type p53 in human cancer cells mediated by recombinant adenovirus", CANCER GENE THERAPY, vol. 1, no. 1, pages 5 - 13 [X] 1 * page 12, column 2, line 17 - line 18 * | [PY] - LEE, M.G. ET AL., "The constitutive expression of the immunomodulatory gp 19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against vector", GENE THERAPY, vol. 2, no. 4, pages 256 - 262 [PY] 1 * the whole document * | [A] - CHANDA, P.K. ET AL., "High level expression of the envelope glycoproteins of the Human Immunodeficiency Virus Type I in presence of rev gene using helper-independent adenovirus type 7 recombinants", VIROLOGY, vol. 175, no. 2, pages 535 - 547 [A] 1 * the whole document * |